Position in VKTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$12,539,809
-$1,093,461 QoQ
Shares Held
385,366
-0.6% QoQ
Ownership
0.332%
of shares outstanding
% of Portfolio
4.78%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026First Washington CORP holds $16,070,756 across 2 Biotechnology names. VKTX ranks #1 (78.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
This page
|
385,366 | $12,539,809 | |
| 2 | VCEL |
Vericel Corp
|
109,759 | $3,530,947 |
All Filings in VKTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,539,809 | 385,366 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $13,633,270 | 387,529 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,012,634 | 266,843 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,821,773 | 106,482 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,571,540 | 106,482 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,378,868 | 59,117 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,742,697 | 59,117 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,103,966 | 39,690 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $782,116 | 9,538 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,453,559 | 239,310 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||